3Thebaud B, Petit T, de Lagausie P, et al. Altered guanylyl-cydase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia [J]. Am J respir cell mol Boil, 2002,27: 42-47.
4Alano MA, Ngougmna E, Ostrea EM, et al. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn [J]. Pediatrics, 2001, 107: 519-523.
5Fox w, Duara S. Persistent pulmonary hypertension in the neonate:Diagnosis and Management [J]. J Pediatr, 1983, 103:505.
6Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study [J]. Pediatrics,1998, 101 : 325-334.
7Rimensberger PC, Spar-Schopfer I, Berner M, et al. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: Vasodilator capacity and cellular mechanisms [J]. Circulation, 2001, 103:544-548.
8Weinberger B, Weiss K, Heck DE et al. Pharmacologic therapy of persistent pulmonary hypertension of the newborn [J]. Pharmacology & therapeutics, 2001,89: 67-79.
9Shekerdemian L, Ravn H, Penny D. Intravenous Sildenafil Lowers Pulmonary Vacular resistance in a Model of Neonatal Pumonary Hypertension [J]. Am J Respir Crit Care Med, 2002,165: 1098-1102.
10Oliver J, Webb D, Patole S, et al. Sildenafil for "blue babies"[J]. BMJ, 2002, 325 : 1174a.
2Kang JL, Park W, Pack IS, et aL Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation. J Appl Physiol, 2002, 92 : 795-801.
3Hu X, Cao L, Lain LK, et al. Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B. Biol Neonate, 2005, 87:73-81.
4Cao L, Qian LI, Zhu YR, et al. Regulation of activity of nuclear factor-kappa B and activator protein-I by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury. Acta Pharmacol Sin, 2003, 24: 1316-1323.
5Chollet-Martin S, Jourdain B, Gibert C, et al. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med, 1996, 154: 594-601.
6Jean D, Maitre B, Tankovic J, et al. Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearance. Crit Cave Med, 2002, 30: 442-447.
7Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with repiratory failure. N Engl J Med, 2006, 355:354-364.
8Cleary G, Wiswen TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome: an update. Pediatr Clin Noah Am, 1998, 45:511-529.
9Femandez-Martorell P, Rais-Bahrami K, Rivera O, et aL Use of nitric oxide in meconium aspiration syndrome: lack of response.Scand J Clin Lab Invest, 1998, 58:177-181.
10Kinsella JP, Truog WE, Walsh WF, et aL Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr, 1997, 131:55-62.
